Volume 25, Issue 3, Pages (March 2017)

Slides:



Advertisements
Similar presentations
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Induction of Rapid and Highly Efficient Expression.
Advertisements

Volume 17, Issue 4, Pages (April 2009)
Invest. Ophthalmol. Vis. Sci ;54(9): doi: /iovs Figure Legend:
From: Inflammatory Mediators Induced by Amyloid-Beta in the Retina and RPE In Vivo: Implications for Inflammasome Activation in Age-Related Macular Degeneration.
From: Deficiency of SHP-1 Protein-Tyrosine Phosphatase in “Viable Motheaten” Mice Results in Retinal Degeneration Invest. Ophthalmol. Vis. Sci ;47(3):
Genetic Manipulation of Brown Fat Via Oral Administration of an Engineered Recombinant Adeno-associated Viral Serotype Vector  Wei Huang, Travis McMurphy,
Volume 5, Issue 6, Pages (June 2002)
Volume 3, Issue 5, Pages (May 2001)
From: AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo
From: Targeting the Nrf2 Signaling Pathway in the Retina With a Gene-Delivered Secretable and Cell-Penetrating Peptide Invest. Ophthalmol. Vis. Sci ;57(2):
Volume 18, Issue 3, Pages (September 2013)
Volume 8, Issue 2, Pages (August 2003)
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Volume 34, Issue 1, Pages (March 2002)
Volume 82, Issue 1, Pages (April 2014)
Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine 
Volume 16, Issue 3, Pages (March 2008)
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Activation of the Extracellular Signal-Regulated Kinase 1/2 Pathway by AAV Gene Transfer Protects Retinal Ganglion Cells in Glaucoma  Yu Zhou, Vincent.
Volume 23, Issue 8, Pages (May 2018)
Volume 25, Issue 3, Pages (March 2017)
Tumor Necrosis Factor Signaling Mediates Resistance to Mycobacteria by Inhibiting Bacterial Growth and Macrophage Death  Hilary Clay, Hannah E. Volkman,
Volume 142, Issue 3, Pages e2 (March 2012)
Molecular Therapy - Methods & Clinical Development
Volume 21, Issue 10, Pages (October 2013)
Volume 29, Issue 3, Pages (March 2001)
Molecular Therapy - Methods & Clinical Development
Volume 25, Issue 1, Pages (January 2017)
Volume 4, Issue 6, Pages (December 2001)
A Recombinant Baculovirus Efficiently Generates Recombinant Adeno-Associated Virus Vectors in Cultured Insect Cells and Larvae  Yang Wu, Liangyu Jiang,
Volume 19, Issue 2, Pages (February 2011)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Ribosomal Protein S3 Gene Silencing Protects Against Cigarette Smoke-Induced Acute Lung Injury  Jinrui Dong, Wupeng Liao, Hong Yong Peh, W.S. Daniel Tan,
Volume 15, Issue 5, Pages (May 2007)
Molecular Therapy - Methods & Clinical Development
Volume 4, Issue 5, Pages (November 2001)
Volume 94, Issue 6, Pages e4 (June 2017)
Volume 26, Issue 1, Pages (January 2018)
Volume 19, Issue 7, Pages (July 2011)
Molecular Therapy - Methods & Clinical Development
Volume 17, Issue 1, Pages (September 2016)
Volume 3, Issue 4, Pages (April 2001)
Volume 5, Issue 6, Pages (June 2002)
Volume 23, Issue 10, Pages (October 2015)
Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury  Kosuke Fujita, Koji M. Nishiguchi, Yukihiro.
Volume 26, Issue 2, Pages (May 2000)
Volume 17, Issue 5, Pages (May 2009)
Volume 25, Issue 8, Pages (August 2017)
Tumor Necrosis Factor Signaling Mediates Resistance to Mycobacteria by Inhibiting Bacterial Growth and Macrophage Death  Hilary Clay, Hannah E. Volkman,
Volume 23, Issue 2, Pages (February 2015)
Volume 21, Issue 8, Pages (August 2013)
Volume 53, Issue 5, Pages (March 2007)
Improved Retinal Transduction In Vivo and Photoreceptor-specific Transgene Expression Using Adenovirus Vectors With Modified Penton Base  Siobhan M Cashman,
Volume 25, Issue 2, Pages (February 2017)
Molecular Therapy - Methods & Clinical Development
Volume 17, Issue 12, Pages (December 2009)
Volume 8, Issue 2, Pages (August 2003)
Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage  Dan Levy, Yaarit Adamovich,
J.M.I. Malik, Z. Shevtsova, M. Bähr, S. Kügler  Molecular Therapy 
Volume 21, Issue 10, Pages (October 2013)
Long-Term PEDF Release in Rat Iris and Retinal Epithelial Cells after Sleeping Beauty Transposon-Mediated Gene Delivery  Laura Garcia-Garcia, Sergio Recalde,
Volume 20, Issue 4, Pages (April 2012)
Volume 19, Issue 9, Pages (September 2011)
Volume 25, Issue 4, Pages (April 2017)
Michael U. Shiloh, Paolo Manzanillo, Jeffery S. Cox 
Volume 9, Issue 2, Pages (February 2004)
Volume 27, Issue 11, Pages e3 (June 2019)
Specificity of the WDR81 antibody for the antigen.
Long-Term PEDF Release in Rat Iris and Retinal Epithelial Cells after Sleeping Beauty Transposon-Mediated Gene Delivery  Laura Garcia-Garcia, Sergio Recalde,
Molecular Therapy - Methods & Clinical Development
Presentation transcript:

Volume 25, Issue 3, Pages 765-779 (March 2017) AAV-Nrf2 Promotes Protection and Recovery in Animal Models of Oxidative Stress  Katharine J. Liang, Kenton T. Woodard, Mark A. Weaver, John Paul Gaylor, Ellen R. Weiss, R. Jude Samulski  Molecular Therapy  Volume 25, Issue 3, Pages 765-779 (March 2017) DOI: 10.1016/j.ymthe.2016.12.016 Copyright © 2017 Terms and Conditions

Molecular Therapy 2017 25, 765-779DOI: (10.1016/j.ymthe.2016.12.016) Copyright © 2017 Terms and Conditions

Figure 1 AAV-Nrf2 Transduction Drives Nrf2 and Downstream Gene Expression and Decreases ROS In Vitro (A) Western blot verifying NRF2 expression and corresponding densitometric analysis of total γ-glutamylcysteine synthase (γ-GCSm) downstream gene activation following pAAV-Nrf2 transfection compared to no-virus control in 293T cells. Western blot shown is representative of several westerns quantified in corresponding densitometric analysis (n = 4; *p < 0.1, paired t test). (B) Western blot and corresponding densitometric quantitation of pAAV-Nrf2-induced heme oxygenase-1 (HO-1) gene activation and Nrf2-siRNA repression compared to no-virus and pAAV-AAT transfection controls are shown. Lanes 1 and 4, none; lanes 2 and 4, pAAV-CBA-AAT; lanes 3 and 6, pAAV-CBh-Nrf2. (C) Fluorescent ROS assay was used to measure H2O2 and arsenic-induced oxidative stress levels in either untransduced HEK293T cells or cells transduced with 50,000 MOI AAV-Nrf2. Plotted values represent the ratio of fluorescence measured in cells stressed with H2O2 and arsenic to reference cells treated with vehicle (n = 12 paired biological replicates from 12 independent experiments, each n representing the mean value of a triplicate; **p < 0.001, linear mixed model with random plate effects). Molecular Therapy 2017 25, 765-779DOI: (10.1016/j.ymthe.2016.12.016) Copyright © 2017 Terms and Conditions

Figure 2 AAV-Nrf2 Protects Mice from Acute Acetaminophen Toxicity (A) Nrf2 was cloned into AAV2 ITR backbones under the control of a CBA promoter. Nrf2−/− and wild-type mice were injected with AAV2-CBA-Nrf2 prior to the administration of acetaminophen by oral gavage, and they were observed for survival at 24 and 48 hr following oral gavage. (B) AAV-Nrf2 injection of Nrf2−/− mice resulted in protection from acetaminophen-induced lethality (600 mg/kg; exact log-rank test p < 0.001 for Nrf2−/− mice versus Nrf2−/− mice + AAV-Nrf2 at 48 hr). (C) H&E staining of liver sections revealed severe centrilobular necrosis in Nrf2−/− mice following 600 mg/kg acetaminophen stress, which was not present in Nrf2−/− mice that had received AAV-Nrf2 prior to acetaminophen stress (D). (E) AAV-Nrf2 injection of wild-type mice resulted in protection from acetaminophen-induced lethality (1,000 mg/kg; exact log-rank test p = 0.010 for injected versus uninjected mice at 48 hr). H&E staining of liver sections revealed centrilobular necrosis in wild-type mice following 1,000 mg/kg acetaminophen stress (F), which was not present in mice that had received AAV-Nrf2 prior to acetaminophen stress (G). Scale bars, 100 μm. Molecular Therapy 2017 25, 765-779DOI: (10.1016/j.ymthe.2016.12.016) Copyright © 2017 Terms and Conditions

Figure 3 AAV Transduction in the Retina via Intravitreal Delivery (A) eGFP and Nrf2 were cloned into AAV2 ITR backbones under the control of a CBh promoter. (B) Western blot analysis of mouse retinal lysates from uninjected eyes compared to eyes injected with AAV-Nrf2 is shown. The expression of the ARE-controlled gene (HO-1) in Nrf2−/− mouse retina lysates was compared to that from uninjected wild-type mice, as well as to 293T cells that were either untreated or transfected with pAAV-Nrf2. α-tubulin and calnexin were used as loading controls for Nrf2 and HO-1 blots, respectively. (C) AAV2- (upper) and AAV2.5-CBh-GFP- (lower) mediated GFP expression is visualized by in vivo fluorescent fundus in intravitreally injected mouse eyes. (D) Corresponding 10-μm cryosections were immunostained for GFP and the Müller glia marker glutamine synthetase (GS). Scale bars, 50 μm. Molecular Therapy 2017 25, 765-779DOI: (10.1016/j.ymthe.2016.12.016) Copyright © 2017 Terms and Conditions

Figure 4 Retinal Pathology following Light Damage (A) Retinal layers are labeled on in vivo OCT scans and H&E-stained sections from naive adult BALB/c mice. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; IS, inner segment; OS, outer segment. (B) Mice were intravitreally injected with AAV-Nrf2 in one eye and the fellow eye was left uninjected. OCT scans from 1 week and 3 months following light damage were blinded and scored for pathological features (n = 5 mice per group, four scans per eye, 20 scans per group). Retinal pathology scores were plotted as paired values of injected and uninjected eyes from the same animal (detailed scoring table, Table S1). AAV-Nrf2-injected eyes exhibited significantly decreased pathological features compared to uninjected eyes at 3 months following light damage (n = 5; *p = 0.02, paired t test). (C) Representative OCT scans and H&E-stained sections of AAV-Nrf2-injected and uninjected eyes, 1 week and 3 months following exposure to bright white light, are shown. OCT scale bars, 100 μm; H&E scale bars, 60 μm. Molecular Therapy 2017 25, 765-779DOI: (10.1016/j.ymthe.2016.12.016) Copyright © 2017 Terms and Conditions

Figure 5 AAV-Nrf2 Protects Retinal Thickness following Light Damage Total retinal thickness (A) and ONL thickness (B) were evaluated using segmentation of OCT images taken of two separate groups of mouse eyes in parallel in vivo experiments at 1 week and 3 months post-light stress. Prior to light stress, mice (n = 5) were injected in one eye with AAV-Nrf2 (cyan, n = 5 eyes) and the fellow eye was left uninjected (black, n = 5 eyes). Age-matched naive mice (yellow, n = 5 mice, ten eyes) also were compared to light-stressed mice. Individual raw traces of retinal thickness and smoothed mean lines are shown, with gray areas representing ±SD (smoothed) values for each group (complete list of p values, Table S2). Molecular Therapy 2017 25, 765-779DOI: (10.1016/j.ymthe.2016.12.016) Copyright © 2017 Terms and Conditions

Figure 6 Dark-Adapted Retinal Function following Severe Light Damage ERG recordings and amplitudes showing rod-dominated retinal function at 1 week (A and B) and 3 months (C and D) following 3 hr of light stress. (A and C) Representative ERG traces are shown for injected and uninjected eyes. (B and D) Average ERG amplitudes for a-waves (upper) and b-waves (lower) were plotted for mice exposed to light damage following AAV-Nrf2 intravitreal injection (closed black circles) or left uninjected (open circles), compared to age-matched naive mice (gray circles). Error bars represent SEM (n = 5/group; complete list of p values, Tables S3 and S4). Molecular Therapy 2017 25, 765-779DOI: (10.1016/j.ymthe.2016.12.016) Copyright © 2017 Terms and Conditions

Figure 7 Nrf2-ETGE Exhibits Increased ARE Activity In Vitro Nrf2 activity was quantified as a ratio of Firefly to Renilla luciferase activity following transfection of HEK293T cells with ARE-Firefly luciferase, CMV-Renilla luciferase, and Keap1 expression plasmids, along with AAV packaging plasmids CBA-AAT, CBh-Nrf2-WT, or CBh-Nrf2-ETGE. Assay was performed in triplicate and data are reported for three separate biological replicates (black, gray, and open circles). Lines represent geometric means (p < 0.0001 for all comparisons except Nrf2-WT versus Nrf2-ETGE in the absence of Keap1; complete list of p values, Table S5). Molecular Therapy 2017 25, 765-779DOI: (10.1016/j.ymthe.2016.12.016) Copyright © 2017 Terms and Conditions

Figure 8 Dark-Adapted Retinal Function following Moderate Light Damage ERG recordings and amplitudes showing rod-dominated retinal function 1 week (A and B) and 1 month (C and D) following 2 hr of light stress. (A and C) Representative traces are shown for injected and uninjected eyes. (B and D) Average ERG amplitudes for a-waves (upper) and b-waves (lower) were plotted for mice exposed to light damage following AAV-Nrf2 intravitreal injection (closed black circles) or left uninjected (open circles), compared to age-matched naive mice (gray circles). Error bars represent SEM (n = 5 per group; complete list of p values, Tables S3 and S4). Molecular Therapy 2017 25, 765-779DOI: (10.1016/j.ymthe.2016.12.016) Copyright © 2017 Terms and Conditions